What can businesses and clients expect from psychedelic-assisted therapies (PAT)? What are state regulations looking like from a for-profit perspective and what does it take to provide safe, effective and compliant treatments?
Developing a compliance program is a common challenge faced by the cannabis industry. Is it time for the industry to reframe its approach to compliance?